ArticleNature communications2020

Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.

Flavia Chiuppesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.